摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

allyl 2-O-benzyl-3,4-O-isopropylidene-α-D-xylopyranoside | 196859-36-6

中文名称
——
中文别名
——
英文名称
allyl 2-O-benzyl-3,4-O-isopropylidene-α-D-xylopyranoside
英文别名
allyl 2-O-benzyl-3,4-di-O-isopropylidene-α-D-xylopyranoside;(3aR,6S,7R,7aS)-2,2-dimethyl-7-phenylmethoxy-6-prop-2-enoxy-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran
allyl 2-O-benzyl-3,4-O-isopropylidene-α-D-xylopyranoside化学式
CAS
196859-36-6
化学式
C18H24O5
mdl
——
分子量
320.386
InChiKey
VRGUBWLCFRSMPS-TWMKSMIVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    23
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    46.2
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    allyl 2-O-benzyl-3,4-O-isopropylidene-α-D-xylopyranoside盐酸 作用下, 以 甲醇 为溶剂, 反应 0.5h, 以3.87 g的产率得到allyl 2-O-benzyl-α-D-xylopyranoside
    参考文献:
    名称:
    Xylopyranoside-based agonists of d-myo-inositol 1,4,5-trisphosphate receptors: synthesis and effect of stereochemistry on biological activity
    摘要:
    The synthesis of a series of tetrahydrofuranyl alpha- and beta -xylopyranoside trisphosphates, designed by excision of three motifs of adenophostin A is reported. The synthetic route features improved preparations of allyl alpha -D-xylopyranoside and its 2-O-benzyl ether, and gives access to four diastereoisomeric trisphosphates, which show a range of abilities to mobilise Ca2+ from the intracellular stores of hepatocytes. A comparison of the potencies of the four trisphosphates provides useful information relating to the effects of stereochemical variation on the recognition of carbohydrate-based trisphosphates by D-myo-inositol 1,4,5-trisphosphate receptors. 1-O-[(3 'S,4 'R)-3-hydroxytetrahydrofuran-4-yl] alpha -D-xylopyranoside 3,4,3 ' -trisphosphate (8) is the most active member of the series with a potency close to Ins(1,4,5)P-3; a beta -linked analogue, 1-O-[(3 'R,4 'S)-3-hydroxytetrahydrofuran-4-yl] beta -D-xylopranoside 3,4,3 ' -trisphosphate, is ca. 20-fold weaker than Ins(1,4,5)P-3, and the other compounds are much less active. While no compound attained a potency close to that of adenophostin A, we believe that 8 represents the minimal structure for potent Ca2+-releasing activity in this type of carbohydrate-based analogue. (C) 2001 Elsevier Science I,td. All rights reserved.
    DOI:
    10.1016/s0008-6215(01)00067-2
  • 作为产物:
    描述:
    D-吡喃木糖吡啶sodium hydroxide 、 sodium hydride 、 对甲苯磺酸乙酰氯 作用下, 以 四氢呋喃甲醇N,N-二甲基甲酰胺 为溶剂, 反应 20.5h, 生成 allyl 2-O-benzyl-3,4-O-isopropylidene-α-D-xylopyranoside
    参考文献:
    名称:
    Xylopyranoside-based agonists of d-myo-inositol 1,4,5-trisphosphate receptors: synthesis and effect of stereochemistry on biological activity
    摘要:
    The synthesis of a series of tetrahydrofuranyl alpha- and beta -xylopyranoside trisphosphates, designed by excision of three motifs of adenophostin A is reported. The synthetic route features improved preparations of allyl alpha -D-xylopyranoside and its 2-O-benzyl ether, and gives access to four diastereoisomeric trisphosphates, which show a range of abilities to mobilise Ca2+ from the intracellular stores of hepatocytes. A comparison of the potencies of the four trisphosphates provides useful information relating to the effects of stereochemical variation on the recognition of carbohydrate-based trisphosphates by D-myo-inositol 1,4,5-trisphosphate receptors. 1-O-[(3 'S,4 'R)-3-hydroxytetrahydrofuran-4-yl] alpha -D-xylopyranoside 3,4,3 ' -trisphosphate (8) is the most active member of the series with a potency close to Ins(1,4,5)P-3; a beta -linked analogue, 1-O-[(3 'R,4 'S)-3-hydroxytetrahydrofuran-4-yl] beta -D-xylopranoside 3,4,3 ' -trisphosphate, is ca. 20-fold weaker than Ins(1,4,5)P-3, and the other compounds are much less active. While no compound attained a potency close to that of adenophostin A, we believe that 8 represents the minimal structure for potent Ca2+-releasing activity in this type of carbohydrate-based analogue. (C) 2001 Elsevier Science I,td. All rights reserved.
    DOI:
    10.1016/s0008-6215(01)00067-2
点击查看最新优质反应信息

文献信息

  • Moitessier, Nicolas; Maigret, Bernard; Chretien, Francoise, European Journal of Organic Chemistry, 2000, # 6, p. 995 - 1005
    作者:Moitessier, Nicolas、Maigret, Bernard、Chretien, Francoise、Chapleur, Yves
    DOI:——
    日期:——
  • Xylopyranoside-based agonists of d-myo-inositol 1,4,5-trisphosphate receptors: synthesis and effect of stereochemistry on biological activity
    作者:Heidi J. Rosenberg、Andrew M. Riley、Rachel D. Marwood、Vanessa Correa、Colin W. Taylor、Barry V.L. Potter
    DOI:10.1016/s0008-6215(01)00067-2
    日期:2001.5
    The synthesis of a series of tetrahydrofuranyl alpha- and beta -xylopyranoside trisphosphates, designed by excision of three motifs of adenophostin A is reported. The synthetic route features improved preparations of allyl alpha -D-xylopyranoside and its 2-O-benzyl ether, and gives access to four diastereoisomeric trisphosphates, which show a range of abilities to mobilise Ca2+ from the intracellular stores of hepatocytes. A comparison of the potencies of the four trisphosphates provides useful information relating to the effects of stereochemical variation on the recognition of carbohydrate-based trisphosphates by D-myo-inositol 1,4,5-trisphosphate receptors. 1-O-[(3 'S,4 'R)-3-hydroxytetrahydrofuran-4-yl] alpha -D-xylopyranoside 3,4,3 ' -trisphosphate (8) is the most active member of the series with a potency close to Ins(1,4,5)P-3; a beta -linked analogue, 1-O-[(3 'R,4 'S)-3-hydroxytetrahydrofuran-4-yl] beta -D-xylopranoside 3,4,3 ' -trisphosphate, is ca. 20-fold weaker than Ins(1,4,5)P-3, and the other compounds are much less active. While no compound attained a potency close to that of adenophostin A, we believe that 8 represents the minimal structure for potent Ca2+-releasing activity in this type of carbohydrate-based analogue. (C) 2001 Elsevier Science I,td. All rights reserved.
查看更多

同类化合物

苄基二亚苄基-α-D-甘露吡喃糖苷 苄基2-C-甲基-3,4-O-(1-甲基亚乙基)-BETA-D-吡喃核糖苷 艾日布林中间体,艾瑞布林中间体 艾日布林中间体 脱氧青蒿素 甲基6-脱氧-3,4-O-异亚丙基-beta-L-甘油-吡喃己糖苷 甲基3,4-异亚丙基-beta-L-阿拉伯糖吡喃糖苷 甲基3,4-O-异亚丙基-beta-L-赤式-吡喃戊-2-酮糖 甲基3,4-O-(氧代亚甲基)-beta-D-吡喃半乳糖苷 甲基 3,4-O-异亚丙基吡喃戊糖苷 甲基 2,3-O-羰基-4,6-O-异亚丙基-alpha-D-吡喃甘露糖苷 果糖二丙酮氯磺酸酯 果糖二丙酮 托吡酯杂质7 托吡酯N-甲基杂质 托吡酯-13C6 托吡酯 史氏环氧化恶唑烷酮甲基催化剂 双丙酮半乳糖 双丙酮-L-阿拉伯糖 六氢二螺[环己烷-1,2'-[1,3]二氧杂环戊并[4,5]吡喃并[3,2-d][1,3]二恶英-8',1''-环己烷]-4'-醇 [(3aS,5aR,7R,8aR,8bS)-7-(羟基甲基)-2,2,7-三甲基四氢-3aH-二[1,3]二氧杂环戊并[4,5-b:4',5'-d]吡喃-3a-基]甲基氨基磺酸 D-半乳醛环3,4-碳酸 6-脱氧-6-碘-1,2:3,4-二-o-异亚丙基-α-d-半乳糖吡喃糖苷 6-叠氮基-6-脱氧-1,2:3,4-二-o-异亚丙基-d-半乳糖吡喃糖苷 6-O-乙酰基-1,2:3,4-二-O-异亚丙基-alpha-D-吡喃半乳糖 4,5-O-(1-甲基乙亚基)-beta-D-吡喃果糖 3alpha-羟基去氧基蒿甲醚 3-羟基去oxydihydroartemisinin 3,5,11-三氧杂-10-氮杂三环[6.2.1.02,6]十一碳-2(6),7,9-三烯 3,4-O-异亚丙基-L-阿拉伯糖 3,4-O-(苯基亚甲基)-D-核糖酸 D-内酯 3,4,6-三-O-苄基-beta-D-吡喃甘露糖-1,2-(甲基原乙酸酯) 2,6-脱水-5-脱氧-3,4-O-(氧代亚甲基)-1-O-(三异丙基硅烷基)-D-阿拉伯糖-己-5-烯糖 2,3:4,6-二-o-异亚丙基-d-甘露糖苷甲酯 2,3:4,5-二-O-(1-甲基亚乙基)-beta-D-吡喃果糖甲基((((1-(甲硫基)亚乙基)氨基)氧基)羰基)酰胺基亚硫酸酯 2,3:4,5-二-O-(1-甲基亚乙基)-beta-D-吡喃果糖 1-叠氮基硫酸酯 2,3-脱异亚丙基托吡酯 2,3-O-羰基-alpha-d-吡喃甘露糖 2,3-O-(1-甲基亚乙基)-beta-D-吡喃果糖1-氨基磺酸酯 2,3-4,5-二-O-异亚丙基-1-O-甲基-beta-吡喃果糖 2,3,5-三邻苄基-1-o-(4-硝基苯甲酰基)-d-阿拉伯呋喃糖 2,2,2',2'-四甲基四氢螺[1,3-二氧戊环-4,6'-[1,3]二氧杂环戊并[4,5-c]吡喃]-7'-醇 10-乙氧基-1,5,9-三甲基-11,14,15-三氧杂四环[10.2.1.04,13.08,13]十五烷 1-{[(1R,2S,6R)-4,4-二甲基-3,5,10,11-四氧杂三环[6.2.1.02,6]十一烷-7-基]氧基}-3-{[(1S,2R,6S)-4,4-二甲基-3,5,10,11-四氧杂三环[6.2.1.02,6]十一烷-7-基]氧基}-2-丙胺 1-[(3aS,5aR,8aR,8bS)-2,2,7,7-四甲基四氢-3aH-二[1,3]二氧杂环戊并[4,5-b:4',5'-d]吡喃-3a-基]甲胺 1-O-ACETYL-2,3,4,6-DI-O-ISOPROPYLIDENE-Α-D-MANNOPYRANOSE1-O-乙酰基-2,3,4,6-二-O-异亚丙基-Α-D-吡喃甘露糖 1-O-ACETYL-2,3,4,6-DI-O-ISOPROPYLIDENE-Α-D-MANNOPYRANOSE1-O-乙酰基-2,3,4,6-二-O-异亚丙基-Α-D-吡喃甘露糖 1,6-脱水-2,3-O-异亚丙基-β-D-甘露吡喃糖 1,6-去氢-2,3-O-亚苄基-beta-D-吡喃甘露糖